|
TBL1X expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.583900E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.466450E-01 |
| Normal-vs-Stage2 |
9.8493999999949E-05 |
| Normal-vs-Stage3 |
8.176800E-04 |
| Normal-vs-Stage4 |
5.98009999963622E-07 |
| Stage1-vs-Stage2 |
5.776500E-03 |
| Stage1-vs-Stage3 |
9.837200E-03 |
| Stage1-vs-Stage4 |
2.11049999999657E-05 |
| Stage2-vs-Stage3 |
5.125600E-01 |
| Stage2-vs-Stage4 |
3.811000E-01 |
| Stage3-vs-Stage4 |
1.159840E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.575100E-04 |
| Normal-vs-AfricanAmerican |
8.158400E-04 |
| Normal-vs-Asian |
2.575400E-01 |
| Caucasian-vs-AfricanAmerican |
2.780200E-01 |
| Caucasian-vs-Asian |
5.929000E-01 |
| AfricanAmerican-vs-Asian |
9.040600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.5562000000029E-05 |
| Normal-vs-Female |
2.502100E-02 |
| Male-vs-Female |
1.050190E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.04859999999707E-05 |
| Normal-vs-Age(41-60Yrs) |
6.616100E-03 |
| Normal-vs-Age(61-80Yrs) |
3.558500E-04 |
| Normal-vs-Age(81-100Yrs) |
4.227800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.145800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.146410E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.143820E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.774200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.578000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.852000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.189410E-01 |
| Normal-vs-Grade 2 |
4.236000E-02 |
| Normal-vs-Grade 3 |
1.943360E-03 |
| Normal-vs-Grade 4 |
2.83719999716325E-08 |
| Grade 1-vs-Grade 2 |
4.182400E-02 |
| Grade 1-vs-Grade 3 |
2.621500E-02 |
| Grade 1-vs-Grade 4 |
1.959160E-04 |
| Grade 2-vs-Grade 3 |
1.571160E-01 |
| Grade 2-vs-Grade 4 |
7.49839999980573E-07 |
| Grade 3-vs-Grade 4 |
8.157900E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.309600E-01 |
| Normal-vs-ccB subtype |
1.5568000222288E-09 |
| ccA subtype-vs-ccB subtype |
5.52891066263328E-14 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.57339999999585E-05 |
| Normal-vs-N1 |
4.215600E-02 |
| N0-vs-N1 |
2.317200E-01 |
|
|
